| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Technology Officer | See Remarks
1 company
Tyagarajan Seshu is a Chief Technology Officer at Candel Therapeutics, Inc.. Recent SEC Form 4 filings include 2 buys and 6 sells.
Estimated insider holdings value: $759K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2025 | CADL Candel Therapeutics, Inc. | Chief Technology Officer | Sale+OE | 31,278 | $8.82 | $275,947.03 | -26.8% | -41.6% | -41.4% | |
| Jan 15, 2025 | CADL Candel Therapeutics, Inc. | Chief Technology Officer | Sell | 14,322 | $7.23 | $103,476.45 | -12.9% | -38.1% | -25.7% | |
| Jan 8, 2025 | CADL Candel Therapeutics, Inc. | Chief Technology Officer | Sell | 14,545 | $8.22 | $119,533.72 | -11.6% | -49.7% | -36.4% | |
| Nov 29, 2024 | CADL Candel Therapeutics, Inc. | Chief Technology Officer | Sell | 20,392 | $4.56 | $92,897.80 | -14.0% | +82.8% | +1.4% | |
| Jul 17, 2024 | CADL Candel Therapeutics, Inc. | Chief Technology Officer | Sell | 14,851 | $6.47 | $96,124.58 | -9.2% | -9.4% | +5.3% | |
| Jul 11, 2024 | CADL Candel Therapeutics, Inc. | Chief Technology Officer | Sell | 13,330 | $5.97 | $79,625.42 | -7.7% | +1.4% | -1.7% | |
| Dec 9, 2022 | CADL Candel Therapeutics, Inc. | Chief Technology Officer | Buy | 13,358 | $1.88 | $25,060.94 | +445.3% | -16.3% | -56.9% |